MedPath

Sleep Health Education and Social Support Among Blacks With OSA

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Behavioral: Attention Control Group
Behavioral: Peer Based Sleep Health Education and Social Support
Registration Number
NCT02628977
Lead Sponsor
NYU Langone Health
Brief Summary

The primary purpose of this study is to ascertain the effectiveness of tailored, peer based sleep health education and social support in increasing adherence rates to recommended Obstructive Sleep Apnea (OSA) evaluation and treatment among blacks at risk of Obstructive Sleep Apnea.

Detailed Description

Obstructive sleep apnea (OSA), which disproportionately affects blacks (31% vs. 10%, whites), is a critical, preventable and/or treatable disease potentially causing increased cardiovascular disease (CVD) outcomes (e.g., obesity, diabetes, hypertension, stroke, arrhythmia, and chronic heart failure). Improving sleep may have direct effects in reducing CVD risk,2 enhancing brain functions, and increasing workplace productivity. Unfortunately, our focus groups suggest that most at-risk blacks are unaware of OSA symptoms or its related morbidity. Thus, it is imperative to address poor adherence among blacks with OSA, if we are to reduce health disparities associated with CVD outcomes between blacks and whites.

This is a randomized study with a total of 6 sites recruiting; 3 will serve as controls and 3 that will be intervention. Group A participants (Intervention group) will receive health education from a trained Peer Health Educator and Group B participants (Control group) will meet with a salon worker, barbershop worker, or church Health Ministry group leader. Participants will be asked to use a sleep diary and wear a home sleep test device to measure sleep for 7 days. They will be followed for 12 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1092
Inclusion Criteria
  • self-reported race/ethnic minority
  • ages ≥18 years
  • accessible by telephone
  • consent to participate, which includes permission to release medical record information
  • A positive screening for OSA is necessary to be enrolled in the intervention protocol.
Read More
Exclusion Criteria
  • are involved in another sleep study.
  • are unable to understand and sign this informed consent form.
  • know someone who is participating in this study.
  • had a heart attack or stroke within the past 12 weeks.
  • do not identify yourself as a racial/ethnic minority.
  • are pregnant.
  • Refuse to use the ARESTM home sleep test device.
  • Refuse to use the WatchPATTM home sleep test device.
  • are not at risk for sleep apnea.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Attention Control GroupAttention Control GroupParticipants in the attention control group will receive standard sleep literature, providing information about Obstructive Sleep Apnea and access to available sleep services.
OSA Health Education & Support GroupPeer Based Sleep Health Education and Social SupportParticipants randomly assigned to the intervention arm will receive OSA health education and social support from a trained Peer educator.
Primary Outcome Measures
NameTimeMethod
Rate of adherence to recommended home OSA evaluation and treatment after intervention exposure12 Months

We will perform analysis on an intention-to-treat basis.

Secondary Outcome Measures
NameTimeMethod
Rate of Obstructive Sleep Apnea among black men and women at the community level12 Months

Obstructive Sleep Apnea among minorities.

Trial Locations

Locations (1)

180 Madison Ave

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath